Tilray (NASDAQ: TLRY) is a global leader in medical cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis company.
GW Pharmaceuticals (NYSE: GWPH) GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country.
Tier 1 Canadian
Aphria Inc. (NYSE: APHA) Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients, health professionals, and veterans.
Aurora Cannabis Inc.(NYSE: ACB) Aurora Cannabis Inc. produces and distributes medical cannabis products in Canada and internationally.The company’s products consist of dried cannabis and cannabis oil.
CannTrust Holdings Inc.(NYSE: CTST) CannTrust Holdings Inc. produces and distributes pharmaceutical grade medical cannabis products in Canada. It sells dried cannabis and oil extractions to the client based on the medication document provided by health care practitioner.
Canopy Growth Corporation (NYSE: CGC), together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps.
Tier 2 Canadian
Cronos Group Inc. (NASDAQ: CRON) is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana. The firm typically invests in companies based in Canada.
HEXO Corp.(AMEX: HEXO) HEXO Corp., together with its subsidiaries, produces and distributes medical marijuana products. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.
OrganiGram Holdings Inc.(NASDAQ: OGI), through its subsidiaries, produces and sells medical in Canada. It offers marijuana plants, seeds, and cuttings; cannabis oil; and dried flower and cannabis.
Tier 3 Canadian
CannaRoyalty Corp./ Origin House(OTC ORHOF) is a private equity firm specializing in acquisitions. The firm invests in the legal cannabis sector with a focus on research and intellectual property, consumer brands, and industry infrastructure. It seeks to invest in the United States and Canada.
Canaccord Genuity Group Inc.(OTC CCORF) Canaccord Genuity Group Inc., an independent and full-service financial services company.
InMed Pharmaceuticals Inc.(OTC IMLFF) InMed Pharmaceuticals Inc., a pre-clinical stage biopharmaceutical company, researches and develops novel and cannabinoid-based therapies. The company’s lead product is INM-750, a topical cannabinoid product candidate to treat epidermolysis bullosa (EB).
Khiron Life Sciences Corp.(OTC KHRNF) Khiron Life Sciences Corp. develops cannabis products for medical purposes. It also provides cosmeceutical and nutraceutical products.The Toronto-based company is focused on developing markets in Columbia and Latin America.
PharmaCielo Ltd. (OTC PCLOF)PharmaCielo Ltd., cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts and related products in Colombia and internationally.
Phivida Holdings Inc.(OTC PHVAF) Phivida Holdings provides hemp oil extracts to the manufacturers of consumer packaged goods, such as pet supplements, e-juices, topical ointments, cosmetics, and pharmaceuticals; vitamin juices, iced tea products, and nutritional protein shakes; and tinctures and vitamin shots.
Village Farms International, Inc. (NASDAQ: VFF) Village Farms International Inc. is a Canadian vegetable producer. They recently announced an agreement with Emerald Health Therapeutics that will allow both companies to move into low-cost cannabis production.
Willow Biosciences Inc. (OTC: CANSF) engages in the biosynthetic production of plant-derived compounds. The company, through its integrated suite of technologies, developing manufacturing processes for various active pharmaceutical ingredients with various therapeutic benefits, including cancer treatment, pain management, and CNS disorders.
Abacus Health Products, Inc.(OTC: ABAHF), manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemps. The company offers CBD CLINIC line of products for relief from acute musculoskeletal and joint pain.
Acreage Holdings (OTC: ACRGF) Headquartered in New York City, Acreage is a vertically integrated, multi-state owner of cannabis licenses and assets in U.S. states where either medical and/or adult use of cannabis is legal.It currently owns and/or operates cultivation, processing and dispensary operations.
Artelo Biosciences, Inc. (OTC: ARTL), an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutics for the treatment of inflammatory bowel disease, stroke, and rare/orphan diseases; breast cancer, prostate cancer, and neuropathic and nociceptive pain.
C21 Insights (OTC: CBIIF) C21 Insights is a leading provider of predictive analytics tools, data-driven software and services across the cannabis value chain.
Charlottes Web Holdings (OTC: CWBHF) Charlotte’s Web Holdings, Inc. develops and distributes hemp-based cannabidiol (CBD) wellness products. Its products include CBD hemp oils, capsules, topicals, and pet products that feature CBD hemp oil extracts.
Cansortium Inc. (OTC: CNTMF)Cansortium Inc. is a global medical cannabis company operating Florida, Texas, Puerto Rico and Pennsylvania, with licensing pending in Michigan and Canada. The Company also has a licensed cultivation facility in Colombia.
Columbia Care Inc (OTC: CCHWF, develops, manufactures, and markets medical marijuana products. Its products include cannabinoid capsules and medical marijuana tablets.The company also operates medical marijuana dispensaries in the United States.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP)Corbus, a clinical-stage pharmaceutical company, focuses on various therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its lead product candidate is lenabasum, a synthetic endocannabinoid-mimetic drug.
Cresco Labs Inc. (OTC: CRLBF). As one of the fastest-growing companies in cannabis, Cresco Labs leads industry across multiple disciplines. We are involved with every element of the seed-to-sales process – starting with state-of-the-art cultivation facilities, precisely designed to produce thriving cannabis plants.
Curaleaf Hldgs Inc. (OTC: CURLF). Headquartered in Wakefield, Massachusetts, Curaleaf has a presence in 12 states, owns and operates 28 dispensaries, 12 cultivation sites and nine processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York.
Emerald Bioscience, Inc.(OTC: EMBI), a biopharmaceutical company, focuses on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for unmet medical needs worldwide. The company’s lead product candidate is NB1111 for the treatment of glaucoma.
EVIO Inc. (OTC: EVIO), provides analytical testing and advisory services to cannabis industry in the United States. Its testing services comprise identification of compounds and contaminants, as well as screening for residual solvents, pesticides, and hazardous microbiological growth of cannabis products.
4Front Ventures (OTC: FFNTF), leases real estate properties and sells supplies to cannabis cultivators, processors, and dispensaries in the United States and Canada..
Green Thumb Industries Inc (OTC: GTBIF) Green Thumb Industries Inc. manufactures and sells various cannabis products in the United States. The company’s cannabis products include flower, concentrates for dabbing and vaporizing, edibles, and topicals.
Xanthic Biopharma Inc. (OTC: GGBXF), doing business as Green Growth Brands, together with its subsidiaries, engages in the cultivation, processing, production, distribution, and retailing of cannabis and cannabis-infused products in the United States.
Halo Labs Inc.(OTC: AGEEF) Halo Labs Inc. manufactures and sells cannabis oil and concentrates in the United States. It serves licensed retailers and wholesalers. Halo Labs Inc. has a strategic partnership with High Tide Inc. The company was founded in 2016 and is headquartered in Toronto, Canada.
Harvest Health & Recreation Inc. (OTC: HRVSF) Harvest Health & Recreation Inc. is a vertically integrated cannabis company with medical cannabis licenses in nine states and participate in a variety of ways for each facility, from full ownership and operation to design-build expertise and operational consultation.
Innovative Industrial Properties, Inc (NYSE: IIPR) is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.
iAnthus Capital Holdings, Inc. (OTC: ITHUF) iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company is based in New York, New York.
Indus Holding Co. (OTC: INDXF), is a vertically-integrated cannabis company. Based in California, INDUS offers services supporting every step of the supply chain from soil to sale and an extensive portfolio of award-winning brands, including Altai, Dixie, Moon, Beboe and Legal.
Kalytera Therapeutics, Inc. (OTC: KALTF) Kalytera Therapeutics, Inc., a clinical-stage specialty pharmaceutical company,develops cannabinoid medicines for a range of unmet medical needs.The Company was founded in 2014 and is headquartered in Novato,California.
KushCo Holdings, Inc.(OTC: KSHB) KushCo Holdings, Inc., through its subsidiaries, provides various products and services for the regulated cannabis, CBD, and other related industries. It distributes vaporizer products, packaging, supplies, and accessories.
SLANG Worldwide Inc.(OTC: SLGWF) SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company worldwide. The company develops, markets, and distributes a portfolio of branded cannabis products across 2,600 stores in the United States.
TILT Holdings Inc. (OTC: TLLTF) TILT Holdings Inc. is a vertically-integrated infrastructure and technology cannabis company. TILT technologies has a presence in more than 1,000 dispensaries across the U.S., Canada, Puerto Rico and Jamaica.
Trulieve Cannabis Corp. (OTC: TCNNF) Trulieve Cannabis Corp. operates as a medical cannabis company in Florida. It produces include nasal sprays, capsules, concentrates, syringes, cannabis flower in tamper-proof containers for vaporizers, topical creams, tinctures, and vape cartridges.
1933 Industries Inc. (OTC: TGIFF) is a vertically integrated cannabis company with operations in the United States and Canada: Licensed medical and adult-use cannabis cultivation and production assets, CBD infused products, CBD extraction services
Valens Groworks Corp. (OTC: VLNCF), is a biotechnology company, engages in the scientific research of phytopharmaceutical material primarily producing cannabis and cannabis related products. It is also involved in the analytical laboratory testing of cannabis.
Vireo Health International, Inc. (OTC: VREOF) is a physician-founded, patient-focused company. Pending the successful completion of five pending acquisitions, the Company will operate in 11 states.
22nd Century Group, Inc. (OTC: XXII) 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding.
AusCann Group Holdings Ltd (OTC: ACNNF) AusCann Group Holdings Ltd researches, develops, cultivates, produces, and sells clinically validated cannabis medicines to patients in Australia. The company has a strategic partnership with Tasmanian Alkaloids Pty Ltd.
Botanix Pharmaceuticals Limited (Aus: BOT.AX), Botanix Pharmaceuticals Limited, a clinical stage medical dermatology company, develops therapeutics for the treatment of serious skin diseases in Australia.
Cann Group Limited (OTC: CNGGF) Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, and distribution/supply of medicinal cannabis for a range of diseases and medical conditions in Australia. The company was founded in 2015.
Elixinol Global Limited (OTC: ELLXF) Elixinol Global Limited engages in the industrial hemp and medicinal cannabis business in Australia. It manufactures and distributes industrial hemp-based dietary supplements and foods, and skincare products; and medicinal cannabis. The company is based in Sydney, Australia.
Intec Pharma Ltd. (NASDAQ: NTEC), a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology, including Cannabidiol for the treatment of various indications, including low back neuropathic pain and fibromyalgia.